2020 annual financial data
UroGen Pharma 2020 Operating margin
Direct answer
Operating margin was -1,074.15%.
Operating income was -126,739,000 USD and net income was -128,484,000 USD.
Operating cash flow was -105,886,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11,799,000 USD
- Operating income
- -126,739,000 USD
- Net income
- -128,484,000 USD
- Operating cash flow
- -105,886,000 USD